iBio Inc (IBIO)

2.45 +0.04 (+1.66%) USD  |  NYAM  |  Dec 27, 16:00
2.48 +0.03 (+1.22%) After-Hours: 20:00
More

iBio Research and Development Expense (Annual): 5.185M for June 30, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for IBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 0.068M
Palatin Technologies Inc 22.40M
Theriva Biologics Inc 14.31M
Oragenics Inc 15.49M
Nanoviricides Inc 5.437M